U.S. Marine and Shipping Stock News

Founder led companies can appeal when inflation, interest rates and growth signals are pulling in different directions, because leadership is often financially and reputationally tied to long term outcomes. With central banks adjusting policy, bond yields shifting and trade and energy trends in focus, many investors are looking for businesses where decision makers have real skin in the game. This Founder Led Companies screener aims to surface stocks where leadership is closely aligned with...

Amneal Pharmaceuticals (AMRX) is back in focus after a recent review highlighted strong long term shareholder returns, alongside slower projected revenue growth, stagnant free cash flow margins, and mixed outcomes from past growth initiatives. See our latest analysis for Amneal Pharmaceuticals. At a share price of $18.04, Amneal Pharmaceuticals has seen strong short term momentum, with a 30 day share price return of 11.02% and year to date share price return of 42.50%, on top of a 1 year...

With inflation trends mixed, bond yields moving in different directions across regions, and energy prices influenced by supply tensions, investors are paying closer attention to what really underpins a stock: its cash generation. The Undervalued Stocks Based On Cash Flows screener focuses on companies where discounted cash flow estimates from SWS suggest the share price does not fully reflect their cash flow potential. For readers looking for ideas grounded in fundamentals rather than...

Why POET Technologies Is Back on Retail Investors' Radar A sharp single day move of more than 10% in POET Technologies (NasdaqCM:POET) has pulled the stock back into focus, as retail sentiment turns bullish and institutional commentary grows louder. Recent coverage highlights three forces now intersecting around POET Technologies. Retail investors have shifted from a bearish stance to a more optimistic tone, some Wall Street analysts are paying closer attention, and Photon Capital is publicly...

Madrigal Pharmaceuticals (MDGL) has set July 30, 2026 as the date for its second quarter 2026 earnings release, with management hosting a webcast before the U.S. market opens to discuss the results. See our latest analysis for Madrigal Pharmaceuticals. At a share price of $545.53, Madrigal Pharmaceuticals has seen short term share price momentum cool slightly, although its 30 day share price return of 8.85% sits alongside a 1 year total shareholder return of 56.43% and a 5 year total...

Venture Global stock has surged about 80.0% year to date, yet the valuation checks still lean cheap. This sets up a clear question over whether recent enthusiasm around its LNG growth story is matched by a margin of safety in the current price. The roughly 80.0% gain year to date means investors are now paying a much higher price to access the same cash flow potential than they were at the start of 2026. Fresh long term LNG supply contracts and new funding for shipping capacity can support...

Coca-Cola's fairlife dairy subsidiary has been hit by a ransomware attack. The incident has led to a temporary suspension of all U.S. production operations at fairlife. The disruption raises fresh questions about cybersecurity resilience at large consumer brands. Coca-Cola (NYSE:KO) is facing an operational setback after the cybersecurity breach at fairlife, a key dairy subsidiary. With Coca-Cola shares recently at $84.92 and the stock up 2.8% over the past week, 5.8% over the past month,...

Fresh analyst commentary around Chubb (CB) centers on projections for its upcoming earnings report, where Wall Street expects year over year growth in both EPS and revenue, with some attention on potential outperformance versus consensus. See our latest analysis for Chubb. Chubb’s recent 1 month share price return of 4.5% and 1 year total shareholder return of 26.36% suggest momentum has been building, supported by a 3 year total shareholder return of 79.47% and a 5 year total shareholder...

Glaukos (GKOS) has drawn fresh investor attention after its stock closed at $155.39, capping a strong run over the past month and past 3 months without a single defining headline driving the move. See our latest analysis for Glaukos. Glaukos has seen momentum build, with a 30 day share price return of 21.85% and a year to date share price return of 40.34%, alongside a 1 year total shareholder return of 56.96% and 5 year total shareholder return of 210.78%. If Glaukos's recent run has you...

Kaiser Aluminum stock has delivered a 127.7% total return over the past three years, yet current valuation checks suggest it no longer looks like an obvious bargain. The Discounted Cash Flow (DCF) intrinsic value estimate points to a price that is roughly in line with where the shares trade today. After such a strong run, the core question for investors is whether recent growth expectations and operational progress are already well reflected in the current price. The 127.7% return over three...

Global convenience store chains are back in focus after Seven & i’s interest in Poland’s Zabka Group pushed both companies’ shares higher and reminded investors how powerful store expansion and acquisitions can be for growth plans. When a retailer looks to add thousands of locations across new regions, it can reshape the outlook for competitors, suppliers, and landlords as well. This article looks at 3 stocks exposed to the same news theme, all flagged by a Global Convenience Store Expansion...

Ambiq Micro (NYSE:AMBQ) has completed an upsized public equity offering, including the full exercise of the underwriters' overallotment option. The transaction brings in additional capital to the company, expanding its financial resources beyond the initial deal size. This capital raise represents a fresh development for shareholders, with potential implications for Ambiq Micro's growth plans and balance sheet flexibility. Ambiq Micro enters this new phase of funding with shares last...

In recent days, Frontline has drawn increased market attention as heightened trading and options activity coincided with new developments in its global shipping operations, boosting its visibility across the NYSE Composite. This renewed focus on Frontline’s role in worldwide tanker shipping underscores how shifts in seaborne trade patterns can quickly reframe investor interest in the company’s core business. Building on this heightened trading and options activity, we’ll now examine how...

With US 10 year Treasury yields easing to 4.56% after softer inflation data and rising oil prices keeping inflation concerns alive, dividend stocks can look appealing as potential income anchors while markets reassess the interest rate path. This article focuses on dividend paying companies that may be more sensitive to changes in inflation expectations and Fed policy, and are screened for at least a 1% yield and manageable payout ratios. You will see three dividend stocks that appear...

Tapestry stock is coming off a striking run over the past five years, yet its valuation checks now point to a company that no longer looks obviously cheap, with the intrinsic value estimate from a Discounted Cash Flow (DCF) model sitting close to the current share price while traditional multiples lean expensive. Tapestry has delivered a 311.2% return over 5 years, which means anyone holding through that period has already seen a very large amount of value recognized by the market. Future...

First Horizon (FHN) opened Q2 2026 with total revenue of US$871 million and basic EPS of US$0.55, alongside trailing 12 month net income of US$1.03 billion and EPS of about US$2.11. Over recent quarters the company has seen revenue move from US$800 million in Q2 2025 to US$894 million in Q3 2025, US$888 million in Q4 2025, US$847 million in Q1 2026 and now US$871 million. Over the same period, quarterly basic EPS stepped from US$0.46 to US$0.50, US$0.52, US$0.54 and US$0.55. With net margin...

Photronics (PLAB) is back in focus after a securities class action lawsuit followed a sharp share price drop linked to its Q2 2026 results. The report raised questions about disclosures related to demand for high-end integrated circuit photomasks. See our latest analysis for Photronics. The share price reaction to the Q2 report and lawsuit comes after a sharp 40.02% decline in the 90 day share price return, even though Photronics still shows a 47.83% total shareholder return over the past...

Innovative Industrial Properties stock is trading near a 52 week high while both a Discounted Cash Flow (DCF) intrinsic value estimate and earnings based multiples point to the shares screening as undervalued. This sits in tension with a 5 year return that has declined 52.1%. Over the past 5 years, Innovative Industrial Properties has delivered a 52.1% decline, so the recent strength comes against a weak longer term share price record. Recent news around fresh senior and exchangeable note...

Citigroup stock has more than doubled over the past three years, yet current valuation checks suggest the market may still be pricing it below an intrinsic value estimate based on the Excess Returns model. That leaves investors weighing a strong share price recovery against indicators that both the intrinsic value and earnings multiples point to potential undervaluation. Citigroup has delivered a 206.5% return over three years, which puts extra focus on whether the recent share price now...

Silver sits at the crossroads of several powerful trends, with demand tied to AI hardware, solar power and electric vehicles at the same time as global mine investment and production have stalled. That tension in supply and demand has pushed the silver price sharply higher and put pure silver exposure back on many watchlists. For investors who prefer owning businesses rather than raw metals, silver mining stocks can be one way to gain exposure to this theme. This article highlights three...

Incyte (NasdaqGS:INCY) reported new Phase 1/2 data for latarcibart (VGA039), a once monthly subcutaneous therapy for von Willebrand disease. The company highlighted promising safety and efficacy results, including encouraging reductions in bleeding episodes across all VWD types. Incyte has now started a global Phase 3 pivotal program and outlined plans for worldwide regulatory submissions. For investors watching how Incyte (NasdaqGS:INCY) is building beyond its core Jakafi franchise,...

Vistra (VST) is drawing fresh attention after outlining substantial capital plans across nuclear, solar, battery storage, and modernized gas-fired assets, paired with natural gas acquisitions, ahead of its upcoming August 7 earnings release. See our latest analysis for Vistra. Despite the fresh capital plans, Vistra’s recent share price momentum has cooled. The stock closed at US$152.56 and the 1 day, 7 day, 30 day, 90 day and year to date share price returns all showed mid single digit...

In mid-July 2026, Atlassian Corporation announced a broad set of AI-native Jira enhancements, including Teamwork Graph-powered agents, Jira for Slack, Loom-driven task creation, and direct integrations with Claude Code, Cursor, and GitHub Copilot for end-to-end software development workflows. A distinctive element of the launch is that many of these AI agents and automations are available to paid Jira Cloud customers at no additional cost, while new DX AI cost management tools help...

ON Semiconductor stock has delivered a 145.7% return over the past five years, yet recent valuation checks suggest the shares may be trading at a premium to their intrinsic value estimate from a Discounted Cash Flow (DCF) model. That tension between a strong long term result and a DCF view that screens the stock as overvalued is front of mind for investors watching the latest swings in semiconductor sentiment. A 145.7% gain over five years highlights how ON Semiconductor has already...